Sir Gregory Winter at Sydney University, Wednesday 13 November 2019

Dr Robin Fitzsimons invited CamSoc NSW members to hear Trinity College alum Sir Gregory Winter at Sydney University on Wednesday 13 November 2019. Greg shared the 2018 Nobel Prize for Chemistry, and was until recently Master of Trinity. He is a moleclar biologist who "humanized" monoclonal antibodies to enable them to be used therapeutically, across the clinical spectrum from cancer to autoimmune disease to multiple sclerosis to migraine etc. He can reasonably be said to be to modern medicine what Fleming and Florey were to penicillin and the antibiotic era. He had to be his own entrepreneur, and when early on Big Pharma was indifferent he turned to the Australian racing fraternity for seed funding for his first "start-up", Cambridge Antibody Technology. Monoclonals now form the basis of an international pharmaceutical enterprise worth more than $US115 billion.Greg received an Honorory Doctorate in Medical Science the previous week.